Methaqualone, a sedative-hypnotic drug marketed primarily under the brand name Quaalude (and Sopor), was widely prescribed in the 1960s and 1970s to treat insomnia and anxiety. Initially, it was promoted as a non-barbiturate alternative, believed to be safer and less prone to addiction. However, experience revealed significant issues.
The drug’s popularity quickly led to widespread recreational use and abuse. The euphoric and sedative effects were sought after, contributing to its status as a popular party drug. This widespread misuse resulted in a surge of emergency room visits and reports of serious side effects, including seizures, coma, and even death. Addiction rates also became alarmingly high, contradicting the initial claims of safety. The growing public health crisis prompted increased scrutiny and regulatory action.
